Watch the video

Rep. Peter Roskam (R-IL), chairman of the Health Subcommittee on Ways and Means, today stressed the need for Congress to reduce certain regulations on providers that “have no relationship to patient health.” 
 
The AHA has laid out actions that Congress could take to immediately reduce the regulatory burden on hospitals, health systems and the patients they serve. The proposals range from cancelling Stage 3 meaningful use requirements for electronic health records to permanently prohibiting the enforcement of direct supervision requirements in critical access and small or rural hospitals.  
 
Roskam also said that Congress is eager to hear hospital and health system leaders’ opinions on how to handle the opioid epidemic.  
 
“The institutions that you’re leading are right at the center of this, and you have a disproportionately positive influence in this debate,” Roskam said.

[For additional highlights from the AHA Annual Membership meeting, click here.] 

Roskam also addressed the issue of drug pricing, mentioning that President Trump will make an announcement in the next few days that will help “frame the debate moving forward” on the issue. 
 
“We’re not going to stay where we are,” Roskam said. “The place that we are is just completely unsatisfying.”

Related News Articles

Headline
The National Academies of Sciences Engineering, and Medicine yesterday released recommendations for improving outcomes and metrics associated with four grant…
Headline
The Centers for Medicare & Medicaid Services recently announced a six-month delay in implementation of its Innovation Center Maternal Opioid Misuse (MOM)…
Headline
List prices for branded pharmaceutical products in the United States increased 159% between 2007 and 2018, an average of 9.1% per year, according to a study…
Headline
Four drugs used in hospitals for years increased their prices between 525% and 1,644% after receiving formal approval through the Food and Drug Administration’…
Headline
The Food and Drug Administration today approved the first generic albuterol sulfate inhaler to treat and prevent bronchospasms in patients with asthma or…
Headline
Mallinckrodt Pharmaceuticals today announced an agreement in principle on a settlement to resolve all opioid-related claims against the company in…